- Original Article -
CURRENT STATUS OF "HOSPITAL-CLINIC" AND "HOSPITAL-PHARMACY" COOPERATION FOR INHALATION THERAPY -BASED ON HOSPITAL SURVEYS THROUGHOUT JAPANChie Yoshimura1), Yasuyuki Momose2), Takeo Horie3), Yuko Komase4), Akio Niimi5), Kunio Dobashi6), Keisaku Fujimoto7), Yuuji Tohda8), Ken Ohta9) and Mitsuru Adachi10)
1)Respiratory Medicine, Osaka Red Cross Hospital, Osaka, Japan
2)School of Pharmaceutial Sciences International University of Health and Welfare
3)Respiratory Medicine, Maebashi Red Cross Hospital, Maebashi, Gumma
4)Department of Respiratory Internal Medicine, St. Marianna University School of Medicine, Yokohama-city Seibu Hospital
5)Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences
6)Gunma University School of Health Sciences
7)Departments of Clinical Laboratory Sciences, Shinshu University School of Health Sciences
8)The Department of Respiratory Medicine and Allergology, Kinki University, Faculty of Medicine
9)National Hospital Organization, Tokyo National Hospital
10)International University of Health and Welfare, Clinical Medicine Study Center Department of Allergy, Sanno Hospital
Background: The "zero death from asthma strategy" in the medical treatment for bronchial asthma has been promoted by the Ministry of Health, Labour, and Welfare from 2006, and it indicates that medical and non-medical specialists, as well as pharmacists, should cooperate, and strives to build cooperation which is suited the actual conditions of an area. It is also important for COPD. Although hospitals in some areas cooperate with clinics and pharmacies, the overall concept of cooperation appears to be absent in most Japanese hospitals.
Method: A questionnaire was administered in early March, 2012 to 477 allergology institutions, and was authorized by an educational establishment.
Result: Among 246 replies from the institutions, cooperation between hospitals and clinics was carried out by 98 institutions (39.8%) specializing in bronchial asthma, and in 64 institutions (37.2%) specializing in COPD. However, cooperation tools were used in only 37 of these institutions (15.0%). The ability to fill prescriptions outside the hospital was available in 209 institutions (85.0%). One-hundred and seventeen institutions (47.6%) replied that they have no tools for hospital-pharmacy cooperation. Direct indications were written in prescriptions by 82 institutions (33.3).
Conclusion: In order to build inter-regional association and to equalize medical treatment, we suggest that developing tools and organization for cooperation between health professionals who treat patients with bronchial asthma and COPD is necessary.
key words: cooperation tool, hospital and clinic cooperation, hospital and pharmacy cooperation, inhalation therapy
Received: September 18, 2013
Jpn. J. Allergol., 63 (2): 178-186, 2014
Copyright © JAPANESE SOCIETY OF ALLERGOLOGY All rights reserved.